Literature DB >> 10555372

Phylogenetic analysis of Ureaplasma urealyticum--support for the establishment of a new species, Ureaplasma parvum.

F kong1, G James, Z Ma, S Gordon, W Bin, G L Gilbert.   

Abstract

In this study, the phylogenetic relationships between the two biovars and 14 serovars of Ureaplasma urealyticum were studied using the sequences of four different genes or genetic regions, namely: 16S rRNA genes; 16S-23S rRNA gene spacer regions; urease gene subunits ureA, ureB, partial ureC and adjoining regions upstream of ureA, ureA-ureB spacer and ureB-ureC spacer; the 5'-ends of the multiple-banded antigen (MBA) genes. U. urealyticum genotypes, based on all four genomic sequences, could be clearly separated into two clusters corresponding with currently recognized biovars 1 and 2. Sequences were generally conserved within each biovar. However, there was heterogeneity within the 5'-end regions of the MBA genes of the four serovars of biovar 1; the sequence of serovar 3 was identical with the previously published sequence and differed by only three bases from that of serovar 14; but there were significant differences between the sequences of serovars 3 and 14 and those of serovars 1 and 6. Based on the phylogenetic analysis, support is given to previous recommendations that the two biovars of U. urealyticum be classified as distinct species, namely U. parvum and U. urealyticum for biovars 1 and 2, respectively. In the future, the relationship between the new species and clinical manifestations of ureaplasma infections should be studied.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10555372     DOI: 10.1099/00207713-49-4-1879

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  35 in total

1.  Species-specific PCR for identification of common contaminant mollicutes in cell culture.

Authors:  F Kong; G James; S Gordon; A Zelynski; G L Gilbert
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

2.  [Modern diagnostics for urological infections].

Authors:  R Geisel; S Geisel; F-J Schmitz; B Henrich
Journal:  Urologe A       Date:  2003-04-11       Impact factor: 0.639

3.  Nucleotide sequence-based multitarget identification.

Authors:  T Vinayagamoorthy; Kirk Mulatz; Roger Hodkinson
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Simple method for determining biovar and serovar types of Ureaplasma urealyticum clinical isolates using PCR-single-strand conformation polymorphism analysis.

Authors:  D Pitcher; M Sillis; J A Robertson
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  [Non-gonococcal infectious urethritis : pathogen spectrum and management].

Authors:  S Lautenschlager
Journal:  Hautarzt       Date:  2015-01       Impact factor: 0.751

6.  Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 7.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

8.  Rapid detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum organisms in genitourinary samples by PCR-microtiter plate hybridization assay.

Authors:  Takashi Yoshida; Shin-Ichi Maeda; Takashi Deguchi; Takamaro Miyazawa; Hiroaki Ishiko
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Characterization of a murine model of Ureaplasma urealyticum pneumonia.

Authors:  Rose M Viscardi; Jennifer Kaplan; Judith C Lovchik; Ju Ren He; Lisa Hester; Srinivas Rao; Jeffrey D Hasday
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Occurrence of Ureaplasma parvum and Ureaplasma urealyticum in women with cervical dysplasia in Katowice, Poland.

Authors:  Alicja M Ekiel; Daniela A Friedek; Małgorzata K Romanik; Jarosław Jóźwiak; Gayane Martirosian
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.